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ABSTRACT  
 
Objectives To examine whether use of a hand-held fan (‘fan’) improves 
breathlessness and increases physical activity. 
 
Methods A secondary exploratory analysis using pooled data from the fan arms of 
two feasibility randomised controlled trials in people with chronic breathlessness; i) 
fan and activity advice vs activity advice, ii) activity advice alone or with the addition 
or the “calming hand”, or the fan, or both. Descriptive statistics and regression 
analysis to explore patient characteristics associated with benefit (e.g. age, sex, 
diagnosis, general self-efficacy).  
 
Results Forty-one participants were allocated the fan (73 years [IQR 65-76, range 46-
88], 59% male, 20 (49%) chronic obstructive pulmonary disease (COPD), three (7%) 
heart failure, three (7%) cancer). Thirty-five (85%) reported that the fan helped 
breathing, and 22 (54%) reported increased physical activity.   
 
Breathlessness benefit was more likely in older people, those with COPD and those 
with a carer. However, due to the small sample size none of these findings were 
statistically significant. Those with COPD were more likely to use the fan than people 
with other diagnoses (Odds Ratio 5.94 [95% CI (95%CI) 0.63, 56.21, p=0.120)].  
 
Conclusions These exploratory data support that the fan helps chronic 
breathlessness in most people and adds new data to indicate that the fan is 
perceived to increase people’s physical activity. There is also a signal of possible 
particular benefits in people with COPD which is worthy of further study. 
 
Key words airflow; fan; breathlessness; dyspnoea; physical activity  
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INTRODUCTION 
Chronic breathlessness is a common, distressing symptom in people with a range of 
medical conditions[1] and often persists despite optimal treatment of underlying 
disease.[2] There is a developing evidence base for non-pharmacological and 
pharmacological interventions directed at the symptom of breathlessness in its own 
right,[3, 4] in addition to treatment of the causative medical condition(s).  
 
The use of facial airflow to palliate breathlessness was initially reported in 1987.[5] A 
simple method of administrating airflow is the battery operated hand-held fan 
(‘fan’). A recent systematic review [6] included a meta-analysis of fan at rest which 
showed improved subjectively reported breathlessness.[6] An observational 
feasibility study that showed approximately half of the participants with 
breathlessness at rest gained a benefit from fan use that persists until further 
exertion.[7] In a feasibility RCT, more participants still used the fan for 
breathlessness after two months than those in the control intervention.[8] A mixed-
methods feasibility RCT found that patients used the fan as part of a complex 
intervention, had no adverse effects other than a few were embarrassed to use it in 
public, and described benefit in the qualitative data.[9] The authors concluded that a 
further phase III effectiveness trial of the fan alone would give no further value of 
information.  
 
A secondary pooled analysis of qualitative data from 133 participants found over 
80% observed some or substantial benefit from the fan.[10] Other reported benefits 
included: a shortened recovery time from exertion-induced breathlessness; 
improved self-management and feeling more in control; and reduced use of beta-
agonists and oxygen therapy.[10]  
 
These data support the use of the fan in breathlessness alongside other 
management strategies, however, no study has reported how patients use the fan in 
daily life or the fan’s impact on physical activity. We therefore conducted an 
exploratory analysis of patient self-report of fan usage with regard to how it was 
used, benefit gained for breathlessness and any changes in physical activity.  
 4 
 
METHODS 
A secondary analysis was conducted using pooled data from the fan arms from two 
feasibility RCTs in people with chronic breathlessness due to a range of underlying 
medical conditions (mainly chronic obstructive pulmonary disease [COPD], 
interstitial lung disease, heart failure, cancer).  
 
Contributing studies  
Details of the contributory studies are presented in Online Supplementary Table 1. 
Detailed methods are reported in the source references and are summarised here. 
The fan, activity, breathlessness (FAB) study (n=49) was a phase II, multisite, 
international, parallel arm, non-blinded RCT [9] to test the feasibility of conducting a 
definitive trial of the fan for the benefit of breathlessness intensity, in addition to 
simple exercise advice in people with chronic breathlessness. The Calming Hand and 
fan feasibility (CHAFF) study (n = 40) [6] was a 2x2 factorial, feasibility RCT of activity 
advice alone or in addition to the Calming Hand, the fan, or both. In both studies, the 
primary outcomes related to the feasibility of conducting a definitive trial, but data 
were collected on clinical-demographic characteristics and a range of outcome 
measures. Both trials used the same bespoke fan use questionnaire, completed by 
those allocated to the fan arm (Online Appendix 1).  
 
In the FAB and CHAFF studies patients were instructed to hold the fan approximately 
15cm from their face and to direct airflow at their nose and/or mouth. Participants 
were told that the draught of cool air may reduce breathlessness, but not given a 
possible mechanism of action, and they could use it in whichever circumstance they 
wished (at rest, before, during or after exertion).  
 
Ethics approval was in place prior to recruitment for both studies and was not 
required for secondary analysis of anonymised data. Principal investigator approval 
was obtained for data sharing for each study.  
 
Dataset for this study 
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Data from the fan use questionnaires were pooled to form the analysis set.  
 
Analysis 
Descriptive statistics were used to report the patient characteristics and report use 
and benefit from the fan. The median (IQR) was used for continuous data, and n (%) 
for categorical data.  
 
Patient characteristics which might be associated with the primary outcome: benefit 
yes, benefit no, from the questionnaire were explored using logistic regression to 
calculate the odds ratios (95% CIs). Variables associated with benefit (p ≤ 0.1) in the 
univariable analysis or where there was a biological rationale was planned for 
inclusion in a multi-variable logistic regression model. Variables included: age, sex, 
diagnosis, general self-efficacy scale (GSES), or the presence of carers. Analyses were 
conducted using IBM SPSS statistics 24.0.  
 
RESULTS 
Forty-one participants were allocated the fan, median age was 73 years (IQR 65-76 
years, range 46-88 years), 24 (59%) were male. Of the different primary diagnoses 20 
(49%) had COPD, three (7%) heart failure, three (7%) cancer, and 15 (37%) “other”. 
Four (10%) were using long term oxygen therapy, 14 (34%) had an informal carer and 
16 (39%) used a mobility aid. Mean General Self-Efficacy Scale was 31.7 (SD 5) out of 
a maximum of 40 where higher scores indicate more self-efficacy.  
 
Fan Use 
Thirty-five (85%) reported that fan use helped breathlessness, and 22 (54%) felt it 
enabled them to become more physically active.   
 
All participants reported using the fan during the 28-day study period of whom 31 
(76%) used it at least once daily. The median average length of time the fan was used 
for was 3.3 minutes (IQR 2-5 minutes, range 0 to 10 minutes). The fan was used a 
median average of five times daily (IQR 2 to 7, range 0 to 20), with most using it in 
the morning or evening.  
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People with COPD were more likely to use the fan every day: 61% (n=19) daily use 
compared to those with other diagnosis (39% (n=12), odds ratio 5.94 (CI 0.63, 56.21), 
p=0.017.  
 
Predictors of benefit  
Findings from the univariable logistic regression analysis are shown in Table 1. Older 
people, women, those with COPD and those with an informal carer were more likely 
to gain benefit, however, these did not reach statistical significance and the 
confidence intervals were very wide. None of the variables reached the criterion of p 
≤ 0.1, hence a multivariable regression was not conducted. 
 
Table 1. Univariable regression of patient characteristics and help with 
breathlessness.  
 
DISCUSSION  
 The fan helps breathlessness 
 Yes (35) 
Mean (SD), median 
(IQR) or n(%) 
No (6) 
Mean (SD), median 
(IQR) or n(%) 
Odds ratio (95% CI) p-value 
Age 70.7 (9.5) 
73 (66-76) 
66.5 (9.8) 
66 (59-77) 
1.05 (0.96, 1.14) 0.324 
Sex Male 20 83% 4 17% Reference 
 1.50 (0.24, 9.30) 
0.663 
Female 15 88% 2 12% 
Diagnosis COPD 19 95% 1 5% 5.94 (0.63, 56.21) 
Reference 
0.120 
Other 16 76% 5 24% 
Carer Yes 12 86% 2 15% 1.04 (0.17, 6.54) 
Reference 
0.964 
No 23 85% 4 15% 
GSES 31.2 (4.7) 
31 (28-35) 
34.5 (6.6.) 
36 (27-40) 
0.87 (0.72, 1.05) 0.151 
SD – Standard Deviation; CI – confidence intervals; IQR – interquartile range; COPD – chronic 
obstructive pulmonary disease; GSES - general self-efficacy score. 
 7 
This exploratory analysis found that the fan helped chronic breathlessness in 80% 
and increased physical activity in over half.  Three quarters used the fan daily and 
those with COPD were more likely to. Older people, those with a carer and those 
with COPD seemed more likely to gain benefit but these findings did not reach 
statistical significance.  
 
These data are consistent with previous pooled qualitative data showing benefit in 
over 80% participants [10]. However, unlike Luckett et al [10] where participants did 
not refer to increased physical activity directly, these questionnaire data report 
perceived improved physical activity in a significant proportion. This is plausible 
given the reported improvement in recovery from exertion; [11] if patients feel they 
can self-manage recovery from exertion-induced breathlessness (learnt confidence), 
then they would seem more likely to undertake exertion. Of note, participants were 
not given information regarding possible mechanism of action, which may have 
provided additional benefit. [12] Multi-variable analysis of the larger pooled 
qualitative data study failed to demonstrate any statistically significant predictor of 
benefit.[10] Our dataset is too small to draw conclusions about predictors of 
response to the fan although the findings that people with COPD were more likely to 
use the fan daily might point to benefit being more marked in this patient group. The 
signal that benefit might be more likely in people with COPD is interesting; however 
increased use does not necessarily cause benefit. Given the lack of harmful effects 
other than a few patients who did not like the cool air across the face, then a 
pragmatic approach of offering the fan to all irrespective of underlying diagnosis is 
appropriate.   
 
Benefits may feed into self-efficacy of general management of living with chronic 
breathlessness, although our data did not show any relationship with the GSES; the 
study participants had a GSES representative of other populations with chronic 
conditions causing chronic breathlessness.[11]  
 
An exploratory magnetoencephalography study in patients with chronic lung disease 
identified changes in sensory attention in the presence of airflow.[13] A fan may 
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mediate benefit by modulation of central perception of breathlessness [10, 14] 
through trigeminal nerve and vagal afferent stimulation.[14] If patients feel more 
self-efficacious with fan use, they may be enabled to exercise more aiding re-
conditioning over time.  
 
Limitations  
Participants were categorised according to primary diagnosis, but almost half, at 
least of the FAB participants, had multiple diagnoses that could contribute to the 
breathlessness. As participants were able to use the fan as they wished, if there is a 
“dose-response” and benefit depends on adherence, then benefit may be 
underestimated. Conversely, by allowing ad libitum use, we were able to identify 
that those with COPD were more likely to use it daily raising the hypothesis that this 
may be due to greater benefit. 
 
CONCLUSIONS 
Breathlessness is a neglected symptom of many cardio-respiratory conditions, which 
could benefit from fan use in terms of reduced intensity and increased physical 
activity. Due to the small size of this study statistical significance was not gained, 
although trends in certain groups were shown. In the absence of data to identify 
those most likely to benefit, a fan, with appropriate education should be offered as 
part of self-management strategies for breathlessness. 
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